Company intelligence / Profile preview

Fermeate

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Fermeate is an early-stage biotechnology company specializing in precision fermentation to produce high-value bio-based ingredients and therapeutic precursors. The company leverages advanced synthetic biology and microbial engineering to develop sustainable alternatives to traditional chemical synthesis and animal-derived products. By optimizing metabolic pathways in microorganisms, Fermeate aims to scale the production of complex molecules for the healthcare, nutrition, and specialty chemical sectors. Their platform focuses on improving yield, purity, and cost-efficiency for biologics and functional ingredients.

Modalities: BiologicProteinPeptides
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Fermeate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fermeate.

Explore the full profile